The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd & PACs

Creeping Acquisition Near ThresholdOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.74

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.0%+2.0% vs market

Plastic Products - Industrial peers, median of 40sector-1.3%+1.3% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.3 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-2.0+2.0-1.3+1.3

Next day

-8.1-0.1-8.0+0.6-8.7

-6.8-1.6-5.2-0.9-5.8

-5.4-2.7-2.7-1.6-3.9

-4.1+0.3-4.3+0.5-4.5

-10.8+2.0-12.8+1.1-11.9

+2.7+3.7-1.0+0.6+2.1

15d

+14.9+5.2+9.6+1.3+13.6

+8.1+3.3+4.8-1.3+9.4

+16.2+9.0+7.2-0.1+16.3

+14.9+11.8+3.1+5.1+9.8

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 40Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Snehjeev Ventures Pvt Ltd along with persons acting in concert (Rushank S Lunkad, Sneha Lunkad, and Riddhi Lunkad) disclosed an open market acquisition of 32,000 equity shares (0.05%) of Amerise Biosciences Ltd on June 4, 2026. This pushed their combined holding from 46,18,896 shares (6.99%) to 46,50,896 shares (7.04%), crossing the 7% mark and triggering the Reg 29(2) disclosure requirement. The acquirer has clarified that they do not belong to the promoter or promoter group of the company. The company's total equity share capital stands at 66,06,900 shares of Rs. 10 each (Rs. 6.60 crore).

Likely market impact

A non-promoter entity is gradually building a stake in Amerise Biosciences through open market purchases. While the incremental buy is small (0.05%), crossing the 7% threshold signals a creeping acquisition approach that shareholders should monitor, especially as the next major SAST trigger lies at the 10% mark.